RA
CANO

Royce & Associates’s Cano Health, Inc. CANO Stock Holding History

Royce & Associates’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,500
Closed -$1.9M – 1033
2021
Q3 		$1.9M Hold
1,500
– – 0.01% 744
2021
Q2 		$1.81M Buy
+1,500
New +$2.02M 0.01% 770

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates's CANO Position: Q4 2021 in Review

Royce & Associates sold out of Cano Health, Inc. (CANO) in Q4 2021, closing a stake of 1,500 shares — an estimated $1.9M sold.

Royce & Associates first reported a position in CANO in Q2 2021 and held it in 2 quarters. The position peaked at $1.9M in Q3 2021. 130 funds tracked by Wall St. Rank hold CANO as of Q4 2021.

  • Royce & Associates reported no remaining Cano Health, Inc. position as of Q4 2021 after selling out during the quarter.
  • Royce & Associates sold 1,500 Cano Health, Inc. shares in Q4 2021, an estimated $1.9M.
  • Royce & Associates first reported a position in Cano Health, Inc. in Q2 2021 and held it in 2 quarters.
  • Royce & Associates's Cano Health, Inc. position peaked at $1.9M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2021.

Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.